Search Results
Staff
Dr. Bailey-Wilson is a scientist emeritus in NHGRI's Division of Intramural Research.
… and is especially interested in risk factors for lung cancer, prostate cancer, eye disorders, autism and oral clefts. Dr. … served on many scientific advisory boards including the Cancer Family Registry CFRCCS Advisory Board, the World Trade … for mendelian inheritance in the pathogenesis of lung cancer. J Nat Cancer Inst , 82:1272-1279. 1990. [ PubMed ] …
Staff
Dr. Carolyn M. Hutter was the director of the Division of Genome Sciences at the National Human Genome Research Institute.​
… NIH in 2012, serving as a program director in the National Cancer Institute (NCI) Epidemiology and Genomics Research … a program director, serving as the NHGRI team lead for The Cancer Genome Atlas (TCGA) . Prior to NIH, she was a senior staff scientist at the Fred Hutchinson Cancer Research Center and lecturer at the University of …
Educational Resources
A retrovirus is a virus that uses RNA as its genetic material.
… Acquired Immunodeficiency Syndrome (AIDS), Cancer, Cell, Deoxyribonucleic Acid (DNA), Genome, … associated with diseases, including AIDS and some forms of cancer. …
News Release
NHGRI appointed Carolyn Hutter, Ph.D., director of the Division of Genome Sciences, which researches human genome function in health and disease.
… research programs. Most recently, she co-managed The Cancer Genome Atlas (TCGA) - a collaboration between NHGRI and the National Cancer Institute (NCI) - which generated over 2.5 petabytes of publically available genomic data used by the cancer research community to improve the prevention, …
Outreach
15 examples of how genomics has and continues to transform our world in myriad ways.
… Complete Genome Sequence, Genomics Impact On Society, Cancer Genomics, Genomic Testing, Enhanced Forensics, Genome …
Research at NHGRI
Families Sharing Health Assessment and Risk Evaluation (SHARE) helps you and your family learn how your family health history affects your risk for diseases.
… Colorectal Cancer Breast Cancer Prostate Cancer Type 2 Diabetes Heart Disease How to Use the Families … guidelines to reduce risk of heart disease, diabetes, breast cancer, and colorectal cancer . BMC Public Health,  15: …
Genomics and Medicine
Starting in 2019, the American Journal of Human Genetics has published an annual feature identifying ten key advances in applying genomic information to clinical care that were reported in the previous 12 months of published literature. The Genomic Medicine Working Group has authored these reviews, based on its broader effort to identify notable accomplishments in genomic medicine on a monthly basis. From this larger set of published accomplishments, the working group has continued to select ten papers annually to be highlighted as the most significant.
… disease with gene editing 7. Validation of a clinical breast cancer risk assessment tool for all ancestries 8. Broader … with rare diseases 9. Benefits for children with suspected cancer from routine whole-genome sequencing 10. Clinical … Population screening for hereditary breast and ovarian cancer is cost effective Australian …
Clinical Research
The CLINSEQ® Study seeks to learn about the role that your genes play in your health.
… to a variety of conditions, including heart disease, breast cancer, and hearing loss. … Preliminary validation of a consumer-oriented colorectal cancer risk assessment tool compatible with the US Surgeon …
News Release
The Genomics and Society: Expanding the ELSI Universe conference focused on issues arising from the ethical, legal and social implications of genomic research.
… to the genetic testing of women with family histories of breast cancer, genomics is rapidly becoming a fixture in our lives. …
Fact Sheet
Pharmacogenomics is a growing area of genomic medicine that uses a patient's genomic information to help healthcare providers select the medications and dosages that are predicted to work best in each patient.
… testing can be used to determine if the tumor cells in a cancer patient have a specific version of a receptor, which … the choice of treatment. For example, some patients have breast cancers containing a receptor called HER2, which is called HER2-positive breast cancer.  HER2 receptors can cause the cancer to grow …